Title of article
Cdk2 dethroned as master of S phase entry
Author/Authors
Hinds، نويسنده , , Philip W، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2003
Pages
3
From page
305
To page
307
Abstract
The prevailing view of cdk2 as a critical regulator of cell cycle progression and optimal therapeutic target in cancer cells is now challenged by the observation that tumor cells deficient in cdk2 protein and kinase activity are not impaired in proliferation.
Journal title
Cancer Cell
Serial Year
2003
Journal title
Cancer Cell
Record number
1334993
Link To Document